Dr. Rowe is a pioneer in the field of personalized therapeutics for cystic fibrosis (CF), cutting-edge discovery in airway disease biology, and translational research in COPD. He is an international authority in the design and conduct of clinical trials targeting the basic CF defect, and has made key advances in the measurement and interpretation of CFTR function in humans and animals. Dr. Rowe co-invented one-micron resolution optical coherence tomography (Micro-OCT) that captures 3D imaging in real-time at the cellular level, and with his collaborators is the first to bring this technique in vivo in humans. Dr. Rowe is Director of the Gregory Fleming Cystic Fibrosis Research Center at UAB, which involves over 100 faculty members and has been continuously funded for over 25 years. He presently has a laboratory of over 25 individuals, embracing lung research from basic discovery, to translational science, to clinical application.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more